
siRNA干扰Caco-2细胞鞘磷脂合酶2 (SMS2)基因对药物转运体的影响
Effects of sphingomyelin synthase 2 (SMS2) interefered by siRNA on drug transporters in Caco-2 cells
目的 研究鞘磷脂合酶2 (sphingomyelin synthase 2,SMS2)缺损对人结肠癌细胞(colon cancer cell,Caco-2)中药物转运体P糖蛋白(P-glycoprotein,P-gp)及多药耐药相关蛋白2 (multidrug resistance-associated protein 2,MRP2)的表达与功能的影响。方法 SMS2特异性siRNA转染至Caco-2细胞。采用RT-PCR和real-time PCR检测SMS2-特异性siRNA的干扰效率;采用Western blot法检测siRNA转染后P-gp和 MRP2蛋白表达的变化;采用胞内蓄积试验,通过HPLC检测P-gp及MRP2专一性底物罗丹明123及普伐他汀的蓄积含量,分析下调SMS2水平对Caco-2细胞中P-gp及MRP2功能的影响。结果 应用siRNA下调SMS2水平后,P-gp和MRP2的蛋白质水平均显著下调;胞内蓄积实验结果显示罗丹明123及普伐他汀的蓄积量明显增加,说明P-gp和MRP2的外排功能减弱。结论 SMS2基因表达下调对Caco-2细胞中P-gp和MRP2的表达以及功能均有显著影响。
Objective To study the effect of sphingomyelin synthase 2 (SMS2) defect on the expression and function of drug transporters P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (MRP2) in human colon cancer (Caco-2) cells.Methods SMS2-specific siRNA was transfected into Caco-2 cell.RT-PCR and real-time PCR were employed to detect the efficiency of siRNA.Western blot was used to examine the protein expressions of P-gp and MRP2.Intracellular accumulation experiment was carried out to evaluate the effect of SMS2 down-regulation level on the functions of P-gp and MRP2 in Caco-2 cells.HPLC analysis was used to decect the accumulation amounts of parvastain and rhodamine 123,the specific substrates of P-gp and MRP2.Results The expressions of P-gp and MRP2 were downregulated in SMS2 knockdown cells treated by siRNA.Cellular accumulation experiments revealed that the excretion function of P-gp and MRP2 in SMS2 deficient cells was decreased,as the accumulation of rhodamine 123 and parvastain was increased significantly.Conclusions The down-regulation of SMS2 gene on the expression and function of P-gp,MRP2 in Caco-2 cell.
siRNA干扰 / 鞘磷脂合酶2 (SMS2) / P-糖蛋白(P-gp) / 多药耐药相关蛋白2 (MRP2) {{custom_keyword}} /
siRNA interference / sphingomyelin synthase 2 (SMS2) / P-glycoprotein (P-gp) / multidrug resistance-associated protein 2 (MRP2) {{custom_keyword}} /
国家自然科学基金(81373396);教育部博士点基金(20130071110037);上海市科委生物医药重点课题(12431900204)
/
〈 |
|
〉 |